📘 A Deep-Dive for Long-Term Investors | FY26–FY35 Outlook | Date: 31st July 25
Indian Renewable Energy Development Agency Ltd (IREDA) is a government-backed non-banking financial company (NBFC) under the Ministry of New and Renewable Energy (MNRE), primarily focused on funding renewable energy and energy efficiency projects across India.
Since its incorporation, IREDA has played a pivotal role in India’s energy transition by financing solar, wind, biomass, hydro, and other clean energy projects.
India’s target of 500 GW of non-fossil fuel capacity by 2030 demands over ₹20 lakh crore in investments. The government’s focus on energy security, sustainability, and climate action has created a multi-decade runway for clean energy NBFCs like IREDA.
📊 Key Drivers of Industry Growth:
Regulatory push via Renewable Purchase Obligations (RPOs)
Green Hydrogen & Solar Missions
ESG-led global investment flows
Decarbonization mandates for corporates and utilities
📌 CAGR (FY20 to FY25):
AUM: ~29%
Revenue: ~24%
Profit: ~45%
🔍 Comment: Stable margins above 22% post FY22, though Q1 FY26 shows a dip due to one-time impairment cost.
⚠️ One-time impairment cost led to margin compression; investors should monitor asset quality.
📌 Valuation is moderating post IPO but remains at a premium, driven by growth visibility.
📌 Suitable for green energy-focused portfolios or ESG mandates.
IREDA Monthly Chart Outlook:
📉 Recent consolidation near ₹150 after IPO listing
📍 Support Zones: ₹150–₹105
🎯 Upside Targets: ₹260 over 1–2 years
🟩 Strong base formation underway; ideal for staggered accumulation
IREDA is a strategic green lender with long-term potential. While short-term margin pressure and GNPA uptick raise caution, the long-term opportunity in clean energy lending is massive.
📈 Risk:
GNPA may remain elevated near term
Interest rate volatility can impact spreads
📈 Reward:
Structural growth tailwinds
Government backing ensures stability
Valuation comfort improving post correction
Fair Value of IREDA:
This blog is for informational purposes only and not a stock recommendation.